Document Details
Form
Filing Date
Jan 31, 2024
Document Date
Jan 30, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
ArriVent Biopharma
Issuer
ARRIVENT BIOPHARMA, INC.
Filer
ORBIMED ADVISORS LLC